MoldCo operates the first clinician-led digital health service focused on making mold detox a routine component of preventative care. Through its telehealth platform, patients can obtain symptom screening, advanced biomarker lab tests starting at $99, virtual consultations with certified mold-toxicity specialists, and prescription therapies shipped directly to their homes. Typical treatment plans cost $150–$300 per month, positioning MoldCo as a far cheaper alternative to fragmented, in-person options that can run into the tens of thousands of dollars. The company is already offering lab testing in 46 states and clinical care in select states such as Florida, Massachusetts, Michigan, Ohio, and Texas, with nationwide coverage targeted for 2026. Near-term priorities include expanding its specialist network, enhancing proprietary care technology, scaling patient onboarding, and launching clinical research collaborations to raise physician and public awareness. Backed by leading physicians, researchers, and tech VCs, MoldCo has raised $11 million to date to accelerate these initiatives.

Total raised

$11M

Funding rounds

2

Latest round

Seed

Latest activity

Sep 2025